Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live

United States — Food and Drug Administration & Linda Marban

3 shared events · Importance 3 · Last updated Sep 03, 2026

Importance
3
Shared Events
3
Actions
0
Sentiment
0
Live sentiment trends, interaction importance charts, and action volume tracking available on the Ergen Dashboard
79
Regulatory
United States — Food and Drug Administration: Regulator whose briefing documents and advisory committee vote triggered the stock collapse and legal actions.
Linda Marban: CEO who made positive statements about Deramiocel; now named in securities fraud lawsuits.
Jul 27, 2026 · 305 articles
60
Regulatory
United States — Food and Drug Administration: The United States — Food and Drug Administration's Cellular, Tissue, and Gene Therapies Advisory Committee is convening a meeting to review Paragon Therapeutics' Biologics License Application for Deramiocel, which is a critical step in the regulatory approval process for the drug.
Linda Marban: Linda Marban, CEO of Paragon Therapeutics, expressed confidence in the evidence supporting Deramiocel and emphasized the company's commitment to bringing the therapy to patients.
Jun 26, 2026 · 6 articles
42
Regulatory
United States — Food and Drug Administration: The FDA's July 27, 2026 briefing documents and July 29 advisory committee meeting triggered the stock collapse underlying the lawsuit, and its extension of the Deramiocel PDUFA date to November 22, 2026 keeps the review active.
Linda Marban: Capricor's CEO, whose positive statements about HOPE-3 and Deramiocel are cited in the complaint as materially misleading.
Aug 10, 2026 · 267 articles
ERGEN INTELLIGENCE
Explore this relationship live

Track how United States — Food and Drug Administration and Linda Marban interact across events, view sentiment trends, and discover connected entities.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.